Issue navigation
Volume 184, Issue 3, 1 March 2021
Issue Information
Issue Information
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Pages i–v, https://doi.org/10.1111/bjd.19233
Editor's Choice
Editor’s Choice
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Page ix, https://doi.org/10.1111/bjd.19748
EDITORIAL
New international reporting guidelines for clinical trials evaluating effectiveness of artificial intelligence interventions in dermatology: strengthening the SPIRIT of robust trial reporting
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Pages 381–383, https://doi.org/10.1111/bjd.19616
COMMENTARIES
What is new in the 2020 British guidelines for cutaneous squamous cell carcinoma?
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Pages 384–385, https://doi.org/10.1111/bjd.19861
Better reporting of safety data in clinical trials of biologic drugs in psoriasis is still needed
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Page 385, https://doi.org/10.1111/bjd.19434
Tralokinumab for atopic dermatitis: a promising new therapy
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Pages 386–387, https://doi.org/10.1111/bjd.19699
What determines the treatment persistence in paediatric psoriasis?
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Pages 387–388, https://doi.org/10.1111/bjd.19436
Tight junctions in the skin: still a lot to learn
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Pages 388–389, https://doi.org/10.1111/bjd.19390
Light in the dark: distinct effects of dimethyl fumarate on different T‐cell subsets in psoriasis treatment
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Pages 389–390, https://doi.org/10.1111/bjd.19407
Co‐occurrence of TERT promotor mutations with BRAF or NRAS alterations correlates with worse prognosis in melanoma
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Pages 390–391, https://doi.org/10.1111/bjd.19416
Early life regulation of inflammation in atopic dermatitis by microRNA
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Pages 391–392, https://doi.org/10.1111/bjd.19475
Reviews
REVIEW ARTICLE
Treatment of hereditary palmoplantar keratoderma: a review by analysis of the literature
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Pages 393–400, https://doi.org/10.1111/bjd.19144
Evidence‐Based Dermatology
GUIDELINE
British Association of Dermatologists guidelines for the management of people with cutaneous squamous cell carcinoma 2020
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Pages 401–414, https://doi.org/10.1111/bjd.19621
SYSTEMATIC REVIEW
Meta‐analysis results do not reflect the real safety of biologics in psoriasis
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Pages 415–424, https://doi.org/10.1111/bjd.19244
Original Articles
CLINICAL TRIALS
Secukinumab shows high and sustained efficacy in nail psoriasis: 2.5‐year results from the randomized placebo‐controlled TRANSFIGURE study
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Pages 425–436, https://doi.org/10.1111/bjd.19262
Tralokinumab for moderate‐to‐severe atopic dermatitis: results from two 52‐week, randomized, double‐blind, multicentre, placebo‐controlled phase III trials (ECZTRA 1 and ECZTRA 2)
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Pages 437–449, https://doi.org/10.1111/bjd.19574
Tralokinumab plus topical corticosteroids for the treatment of moderate‐to‐severe atopic dermatitis: results from the double‐blind, randomized, multicentre, placebo‐controlled phase III ECZTRA 3 trial
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Pages 450–463, https://doi.org/10.1111/bjd.19573
EPIDEMIOLOGY
Treatment persistence in paediatric and adolescent patients with psoriasis followed into young adulthood. From topical to systemic treatment: a prospective, longitudinal, observational cohort study of 448 patients
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Pages 464–472, https://doi.org/10.1111/bjd.19301
QUALITATIVE AND OUTCOMES RESEARCH
Hyperhidrosis Quality of Life Index (HidroQoL©): further validation and clinical application in patients with axillary hyperhidrosis using data from a phase III randomized controlled trial
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Pages 473–481, https://doi.org/10.1111/bjd.19300
TRANSLATIONAL RESEARCH
Organic osmolytes increase expression of specific tight junction proteins in skin and alter barrier function in keratinocytes
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Pages 482–494, https://doi.org/10.1111/bjd.19162
Dimethyl fumarate modulates the Treg–Th17 cell axis in patients with psoriasis
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Pages 495–503, https://doi.org/10.1111/bjd.19229
Clinical, environmental and histological distribution of BRAF, NRAS and TERT promoter mutations among patients with cutaneous melanoma: a retrospective study of 563 patients
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Pages 504–513, https://doi.org/10.1111/bjd.19297
MicroRNA analysis of childhood atopic dermatitis reveals a role for miR‐451a
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Pages 514–523, https://doi.org/10.1111/bjd.19254
MEDICAL DERMATOLOGY
Should we be imaging lymph nodes at initial diagnosis of early‐stage mycosis fungoides? Results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) international study
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Pages 524–531, https://doi.org/10.1111/bjd.19303
PAEDIATRIC DERMATOLOGY
The challenging management of a series of 43 infants with Netherton syndrome: unexpected complications and novel mutations
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Pages 532–537, https://doi.org/10.1111/bjd.19265
GENERAL DERMATOLOGY
The effect of a dermato‐oncological training programme on the diagnostic skills and quality of referrals for suspicious skin lesions by general practitioners
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Pages 538–544, https://doi.org/10.1111/bjd.19214
Correspondence
PERSPECTIVES
A call to standardize the BCC:SCC ratio
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Page 545, https://doi.org/10.1111/bjd.19550
The climate emergency: why should dermatologists care and how can they act?
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Pages 546–547, https://doi.org/10.1111/bjd.19610
RESEARCH LETTERS
Efficacy and safety of ixekizumab after switching from fumaric acid esters or methotrexate in patients with moderate‐to‐severe plaque psoriasis naïve to systemic treatment
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Pages 548–550, https://doi.org/10.1111/bjd.19558
Efficacy of topical ropivacaine in children and young adults with hereditary epidermolysis bullosa
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Pages 550–552, https://doi.org/10.1111/bjd.19551
Effectiveness of clindamycin and rifampicin combination therapy in hidradenitis suppurativa: a 6‐month prospective study
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Pages 552–553, https://doi.org/10.1111/bjd.19578
Investigating human eyelash hair follicle growth in situ and ex vivo: a pilot study
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Pages 553–555, https://doi.org/10.1111/bjd.19593
Antidrug antibodies to tumour necrosis factor inhibitors in hidradenitis suppurativa: a systematic review
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Pages 555–557, https://doi.org/10.1111/bjd.19591
A qualitative exploration of the experiences of adolescents with alopecia areata and their messages for healthcare professionals
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Pages 557–559, https://doi.org/10.1111/bjd.19598
Efficacy of in‐class interleukin‐23 inhibitor switching: risankizumab following guselkumab failure in moderate‐to‐severe psoriasis treatment
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Pages 559–561, https://doi.org/10.1111/bjd.19575
Long‐term effectiveness of dupilumab up to 52 weeks in atopic dermatitis in 253 adult patients
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Pages 561–563, https://doi.org/10.1111/bjd.19577
Motives for intentional sunlight exposure among young adult sexual minority men: appearance, relaxation and socialization in a cohort study
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Pages 563–564, https://doi.org/10.1111/bjd.19609
Clinical response to immune checkpoint inhibition in patients with advanced skin cancers receiving concurrent ruxolitinib therapy for haematological malignancy
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Pages 564–566, https://doi.org/10.1111/bjd.19604
Patient age and risk of recurrence of primary melanoma at high risk of spread
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Pages 566–568, https://doi.org/10.1111/bjd.19601
Exploring patient–physician trust dynamics in patients with psychocutaneous and general dermatological disease
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Pages 568–570, https://doi.org/10.1111/bjd.19622
Hidradenitis suppurativa and perceived stigmatization in a diverse Canadian clinic population: a pilot study
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Pages 570–571, https://doi.org/10.1111/bjd.19626
Prevalence of allergic contact dermatitis to decyl and lauryl glucoside in the UK and Ireland
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Pages 571–573, https://doi.org/10.1111/bjd.19603
Identifying the required degree of disease clearance to improve quality of life in pemphigus vulgaris
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Pages 573–575, https://doi.org/10.1111/bjd.19625
Occupational dermatoses during the COVID‐19 pandemic: a multicentre audit in the UK and Ireland
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Pages 575–577, https://doi.org/10.1111/bjd.19632
Enhanced expression of angiotensin‐converting enzyme 2 in psoriatic skin and its upregulation in keratinocytes by interferon‐γ: implication of inflammatory milieu in skin tropism of SARS‐CoV‐2
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Pages 577–579, https://doi.org/10.1111/bjd.19670
LETTERS TO THE EDITOR
A changed life: the life experiences of patients with psoriasis receiving biological treatment
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Page 580, https://doi.org/10.1111/bjd.19623
Response to ‘Reduction in skin cancer diagnosis, and overall cancer referrals, during the COVID‐19 pandemic’
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Pages 580–581, https://doi.org/10.1111/bjd.19667
The value of case reports and spontaneous reporting systems for pharmacovigilance and clinical practice
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Pages 581–583, https://doi.org/10.1111/bjd.19677
CORRESPONDENCE: IMAGE GALLERY
Infantile bullous pemphigoid following serogroup B meningococcal vaccination
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Page e53, https://doi.org/10.1111/bjd.19480
Shades of grey: an outbreak of tattoo‐associated Mycobacterium chelonae
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Page e54, https://doi.org/10.1111/bjd.19487
Actinomycetoma caused by Nocardia asiatica associated with traditional Chinese medicine foot bath
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Page e55, https://doi.org/10.1111/bjd.19566
ABSTRACTS
Revolutionizing Atopic Dermatitis, 13–14 December 2020
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Pages e56–e87, https://doi.org/10.1111/bjd.19722
PLAIN LANGUAGE SUMMARIES
Analysis of small RNA molecules in childhood atopic dermatitis reveals a role for miR‐451a
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Page e88, https://doi.org/10.1111/bjd.19765
A study into how the skin retains its moisture levels
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Page e89, https://doi.org/10.1111/bjd.19766
What’s the best treatment for inherited hard skin on the palms and soles?
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Page e90, https://doi.org/10.1111/bjd.19767
How do some genetic mutations affect the outcome of patients with skin melanoma?
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Page e91, https://doi.org/10.1111/bjd.19768
Treatment with secukinumab is highly effective in clearing nail psoriasis: long‐term results from the TRANSFIGURE clinical trial
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Page e92, https://doi.org/10.1111/bjd.19769
Improving skin cancer care with a general practitioner training programme
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Page e93, https://doi.org/10.1111/bjd.19770
Persistence of treatments in children with psoriasis followed into young adulthood: from topical to systemic treatments
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Page e94, https://doi.org/10.1111/bjd.19771
Lessons from 43 infants with Netherton syndrome
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Page e95, https://doi.org/10.1111/bjd.19772
New understanding of how treatment with dimethyl fumarate leads to improvements in psoriasis symptoms
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Page e96, https://doi.org/10.1111/bjd.19773
Serious adverse events in trials evaluating biologics in psoriasis
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Page e97, https://doi.org/10.1111/bjd.19774
Should patients with early mycosis fungoides, a skin cancer of immune cells, undergo imaging to detect lymph node involvement?
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Page e98, https://doi.org/10.1111/bjd.19775
Quality assessment of a quality‐of‐life questionnaire for patients with hyperhidrosis
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Page e99, https://doi.org/10.1111/bjd.19776
Guidelines for the management of people with cutaneous squamous cell carcinoma
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Page e100, https://doi.org/10.1111/bjd.19777
Two identically designed studies to test the effectiveness of tralokinumab for treatment of atopic dermatitis in adults
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Pages e101–e102, https://doi.org/10.1111/bjd.19778
Studying the effectiveness of the drug tralokinumab plus topical corticosteroids for the treatment of atopic dermatitis in adults
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Pages e103–e104, https://doi.org/10.1111/bjd.19779
对儿童特应性皮炎中小 RNA 分子的分析揭示 miR‐451a 的作用
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Page e105, https://doi.org/10.1111/bjd.19780
一项关于皮肤如何保持水分的研究
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Page e106, https://doi.org/10.1111/bjd.19781
对于手掌和足底遗传性硬皮, 最好的治疗方法是什么?
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Page e107, https://doi.org/10.1111/bjd.19782
一些基因突变如何影响皮肤黑色素瘤患者的结局?
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Page e108, https://doi.org/10.1111/bjd.19783
苏金单抗治疗对清除指甲银屑病非常有效: TRANSFIGURE 临床试验的长期结果
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Page e109, https://doi.org/10.1111/bjd.19784
通过全科医生培训计划改善皮肤癌护理
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Page e110, https://doi.org/10.1111/bjd.19785
随访至青年期的银屑病患儿治疗的持续性: 从外用治疗到全身治疗
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Page e111, https://doi.org/10.1111/bjd.19786
43 例 Netherton 综合征婴儿的经验教训
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Page e112, https://doi.org/10.1111/bjd.19787
对富马酸二甲酯治疗如何改善银屑病症状的新的认识
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Page e113, https://doi.org/10.1111/bjd.19788
评估银屑病所用的生物制剂的试验中的严重不良事件
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Page e114, https://doi.org/10.1111/bjd.19789
早期蕈样真菌病 (免疫细胞的皮肤癌) 患者是否应进行成像检查以检测淋巴结受累?
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Page e115, https://doi.org/10.1111/bjd.19790
多汗症患者生活质量调查问卷的质量评估
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Page e116, https://doi.org/10.1111/bjd.19791
皮肤鳞状细胞癌患者的管理指南
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Page e117, https://doi.org/10.1111/bjd.19792
两项设计相同的研究, 旨在测试 tralokinumab 治疗成人特应性皮炎的有效性
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Pages e118–e119, https://doi.org/10.1111/bjd.19793
研究药物 tralokinumab 联合外用皮质类固醇治疗成人特应性皮炎的有效性
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Pages e120–e121, https://doi.org/10.1111/bjd.19794
